ALFA Filings
Every announcement, straight from the exchange
Every Sumitomo Chemical India earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Sumitomo Chemical delivered stable H1 performance despite India's fourth weakest monsoon since 2001. Management maintained 20%+ EBITDA margins through cost control and a 22% value growth in specialty products, offsetting volume declines in generic segments.
Q2FY27 revenue Rs907 Cr (-2% YoY), PAT Rs157 Cr (-11%), EBITDA margin 20.5% (-297bps). H1FY27 PAT up 5% to Rs372 Cr on revenue down 1%. Volume-led weakness; inventory cost mismatch hit margins.
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.
Sumitomo Chemical delivered record profitability in a challenging FY26, reporting its highest-ever margins. Strategy focuses on specialty products, digital outreach, and upcoming leadership transition in September 2026.
Sumitomo Chemical India (SCIL) delivered record FY26 profits despite industry headwinds. Revenue grew 3% to ₹3,238cr, while PAT rose 7% to ₹543cr (16.8% margin), supported by favorable product mix and disciplined pricing.